Researchers recruit participants for new stop smoking study Researchers at UMDNJ-Robert Wood Johnson Medical School (RWJMS) are testing a new stop smoking non-nicotine patch. Approximately 75 people are being recruited to participate in the study conducted by RobertWood Johnson Medical School and sponsored by the National Institutes of Health and the U.S.Department of Veterans Affairs. This is the first time the medication, selegiline,will be used to treat smoking. It will be applied as a skin patch. Selegiline has been approved by the Food and Drug Administration for treatment of other conditions, including depression. It works to reduce or eliminate negative withdrawal symptoms by maintaining levels of dopamine in the body. Dopamine is a neurotransmitter, naturally produced in several areas of the brain. It is stimulated by nicotine when an individual smokes and its reduction can cause withdrawal symptoms or depression. All smokers participating in the study will receive individual counseling and either the new stop smoking medicine or a placebo.They will also receive a free physical. Smokers in the study will be asked to attend several sessions and will be followed for six months.A small payment to cover the time and expense of making clinic visits will be provided. Individuals interested in the participating in the Stop Smoking Study should be daily smokers at least 18 years old who want to stop smoking and are motivated to follow the treatment procedures. To volunteer, smokers in central New Jersey can call (732) 235-3904. For additional information, check the followingWeb site: http://rwjms.umdnj.edu/addiction/participate in_research.htm. The study will be conducted at RobertWood Johnson Medical School at 317 George St., Suite 105,New Brunswick.